Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

CyberKnife radiosurgery for prostate cancer.

Katz AJ.

Technol Cancer Res Treat. 2010 Oct;9(5):463-72.

PMID:
20815417
2.

Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations.

Fuller DB, Naitoh J, Lee C, Hardy S, Jin H.

Int J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1588-97. doi: 10.1016/j.ijrobp.2007.11.067.

PMID:
18374232
3.

Stereotactic body radiotherapy in prostate cancer: is rapidarc a better solution than cyberknife?

Macdougall ND, Dean C, Muirhead R.

Clin Oncol (R Coll Radiol). 2014 Jan;26(1):4-9. doi: 10.1016/j.clon.2013.08.008. Epub 2013 Sep 24.

PMID:
24071450
4.

Dosimetry analyses comparing high-dose-rate brachytherapy, administered as monotherapy for localized prostate cancer, with stereotactic body radiation therapy simulated using CyberKnife.

Fukuda S, Seo Y, Shiomi H, Yamada Y, Ogata T, Morimoto M, Konishi K, Yoshioka Y, Ogawa K.

J Radiat Res. 2014 Nov;55(6):1114-21. doi: 10.1093/jrr/rru048. Epub 2014 Jun 23.

5.

Current role of image-guided robotic radiosurgery (Cyberknife(®) ) for prostate cancer treatment.

Seisen T, Drouin SJ, Phé V, Parra J, Mozer P, Bitker MO, Cussenot O, Rouprêt M.

BJU Int. 2013 May;111(5):761-6. doi: 10.1111/bju.12000. Epub 2013 Jan 31. Review.

6.

Stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience.

Chen LN, Suy S, Uhm S, Oermann EK, Ju AW, Chen V, Hanscom HN, Laing S, Kim JS, Lei S, Batipps GP, Kowalczyk K, Bandi G, Pahira J, McGeagh KG, Collins BT, Krishnan P, Dawson NA, Taylor KL, Dritschilo A, Lynch JH, Collins SP.

Radiat Oncol. 2013 Mar 13;8:58. doi: 10.1186/1748-717X-8-58.

7.

Stereotactic body radiotherapy as monotherapy or post-external beam radiotherapy boost for prostate cancer: technique, early toxicity, and PSA response.

Jabbari S, Weinberg VK, Kaprealian T, Hsu IC, Ma L, Chuang C, Descovich M, Shiao S, Shinohara K, Roach M 3rd, Gottschalk AR.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):228-34. doi: 10.1016/j.ijrobp.2010.10.026. Epub 2010 Dec 22.

PMID:
21183287
8.

Analysis of high-dose rate brachytherapy dose distribution resemblance in CyberKnife hypofractionated treatment plans of localized prostate cancer.

Sudahar H, Kurup PG, Murali V, Mahadev P, Velmurugan J.

Med Dosim. 2013 Winter;38(4):385-9. doi: 10.1016/j.meddos.2013.04.006. Epub 2013 Jun 25.

PMID:
23809693
9.

Potency preservation following stereotactic body radiation therapy for prostate cancer.

Obayomi-Davies O, Chen LN, Bhagat A, Wright HC, Uhm S, Kim JS, Yung TM, Lei S, Batipps GP, Pahira J, McGeagh KG, Collins BT, Kowalczyk K, Bandi G, Kumar D, Suy S, Dritschilo A, Lynch JH, Collins SP.

Radiat Oncol. 2013 Nov 1;8:256. doi: 10.1186/1748-717X-8-256.

10.

High-Dose Robotic Stereotactic Body Radiotherapy in the Treatment of Patients With Prostate Cancer: Preliminary Results in 26 Patients.

Pontoriero A, Iatì G, Mondello S, Midili F, Siragusa C, Brogna A, Ielo I, Anastasi G, Magno C, Pergolizzi S, De Renzis C.

Technol Cancer Res Treat. 2016 Feb;15(1):179-85. doi: 10.1177/1533034614566994. Epub 2015 Jan 13.

PMID:
25586517
11.

A pilot study of intensity modulated radiation therapy with hypofractionated stereotactic body radiation therapy (SBRT) boost in the treatment of intermediate- to high-risk prostate cancer.

Oermann EK, Slack RS, Hanscom HN, Lei S, Suy S, Park HU, Kim JS, Sherer BA, Collins BT, Satinsky AN, Harter KW, Batipps GP, Constantinople NL, Dejter SW, Maxted WC, Regan JB, Pahira JJ, McGeagh KG, Jha RC, Dawson NA, Dritschilo A, Lynch JH, Collins SP.

Technol Cancer Res Treat. 2010 Oct;9(5):453-62.

PMID:
20815416
12.

Is robotic arm stereotactic body radiation therapy “virtual high dose ratebrachytherapy” for prostate cancer? An analysis of comparative effectiveness using published data [corrected].

Zaorsky NG, Hurwitz MD, Dicker AP, Showalter TN, Den RB.

Expert Rev Med Devices. 2015 May;12(3):317-27. doi: 10.1586/17434440.2015.994606. Epub 2014 Dec 25. Review. Erratum in: Expert Rev Med Devices. 2015 Jul;12(4):495.

PMID:
25540018
13.

Stereotactic Body Radiation Therapy for Low- to Intermediate-risk Prostate Adenocarcinoma.

Jeong BK, Jeong H, Ha IB, Choi HS, Kam SC, Hwa JS, Hyun JS, Chung KH, Choi SM, Kang KM.

J Korean Med Sci. 2015 Jun;30(6):710-5. doi: 10.3346/jkms.2015.30.6.710. Epub 2015 May 13.

14.

High-dose-rate stereotactic body radiation therapy for postradiation therapy locally recurrent prostatic carcinoma: Preliminary prostate-specific antigen response, disease-free survival, and toxicity assessment.

Fuller DB, Wurzer J, Shirazi R, Bridge SS, Law J, Mardirossian G.

Pract Radiat Oncol. 2015 Nov-Dec;5(6):e615-23. doi: 10.1016/j.prro.2015.04.009. Epub 2015 Jun 6.

PMID:
26059509
15.

Stereotactic body radiation therapy for prostate cancer: is the technology ready to be the standard of care?

Zaorsky NG, Studenski MT, Dicker AP, Gomella L, Den RB.

Cancer Treat Rev. 2013 May;39(3):212-8. doi: 10.1016/j.ctrv.2012.10.003. Epub 2012 Dec 4. Review.

PMID:
23218442
16.

Image-guided stereotactic body radiation therapy for clinically localized prostate cancer: preliminary clinical results.

Bolzicco G, Favretto MS, Scremin E, Tambone C, Tasca A, Guglielmi R.

Technol Cancer Res Treat. 2010 Oct;9(5):473-7.

PMID:
20815418
17.

Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer.

King CR, Brooks JD, Gill H, Presti JC Jr.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):877-82. doi: 10.1016/j.ijrobp.2010.11.054. Epub 2011 Feb 6.

PMID:
21300474
18.

Stereotactic body radiation therapy for prostate cancer: Rational and reasonable.

Kupelian P, Mehta NH, King C, Steinberg M, Finkelstein SE, Fernandez E.

Pract Radiat Oncol. 2015 May-Jun;5(3):188-92. doi: 10.1016/j.prro.2014.08.018. Epub 2014 Oct 18.

PMID:
25413392
19.

Dosimetric and deformation effects of image-guided interventions during stereotactic body radiation therapy of the prostate using an endorectal balloon.

Jones BL, Gan G, Diot Q, Kavanagh B, Timmerman RD, Miften M.

Med Phys. 2012 Jun;39(6):3080-8. doi: 10.1118/1.4711813.

PMID:
22755693
20.

Stereotactic body radiotherapy as boost for organ-confined prostate cancer.

Katz AJ, Santoro M, Ashley R, Diblasio F, Witten M.

Technol Cancer Res Treat. 2010 Dec;9(6):575-82.

PMID:
21070079

Supplemental Content

Support Center